tiprankstipranks
Trending News
More News >
Protara Therapeutics (TARA)
NASDAQ:TARA

Protara Therapeutics (TARA) Similar Stocks

Compare
684 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Protara Therapeutics
$4.00
$153.32M
42.86%
5 Buy
0 Hold
0 Sell
Strong Buy
Aclaris Therapeutics
$1.13
$121.27M
-8.13%
4 Buy
1 Hold
0 Sell
Strong Buy
Innate Pharma
$1.94
$169.56M
-19.50%
1 Buy
0 Hold
0 Sell
Moderate Buy
4D Molecular Therapeutics
$2.91
$143.54M
-87.91%
7 Buy
1 Hold
1 Sell
Moderate Buy
TriSalus Life Sciences
$5.73
$172.66M
-40.95%
5 Buy
0 Hold
0 Sell
Strong Buy
Molecular Partners
$3.57
$160.44M
-6.54%
3 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TARA
Protara Therapeutics
3.90
1.15
41.82%
ACRS
Aclaris Therapeutics
1.13
-0.10
-8.13%
IPHA
Innate Pharma
1.94
-0.41
-17.45%
FDMT
4D Molecular Therapeutics
3.06
-21.72
-87.65%
TLSI
TriSalus Life Sciences
5.74
-4.09
-41.61%
MOLN
Molecular Partners
3.57
-0.17
-4.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis